Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards Labcyte $196K to Develop Cancer Biomarker Validation System

NEW YORK (GenomeWeb News) – Labcyte today announced it has been awarded $196,000 from the National Cancer Institute for the development of a system for early cancer detection.

The funding will go toward a collaborative cancer biomarker validation program that aims to develop a system that integrates "a suite of well-established biotechnologies," including Labcyte's proprietary acoustic liquid handling for arraying and MALDI mass spectrometry preparation.

The validation program is being done in collaboration with the Canary Center of Stanford University.

The new project could accelerate the biomarker validation process "dramatically," Mark Stolowitz, directory of the proteomic core facility of Stanford, said in a statement, adding that currently "we have a serious throughput problem."

Though there are thousands of candidate biomarkers, each one needs to be validated before they have diagnostic applications. Labcyte's acoustic liquid handling "is an enabling technology that will allow us to speed up the validation process with its precise, accurate, and contamination-free liquid transfer system," he said.

Richard Ellison, CTO of Sunnyvale, Calif.-based Labcyte, said that the firm's acoustic liquid handling technology uses focused ultrasound to "sense and adapt to liquid characteristics, providing both precision in the volume and placement of challenging fluids such as patient samples and volatile reagents."

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.